chr1:162745497:A>T Detail (hg19) (DDR2)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr1:162,745,497-162,745,497 |
| hg38 | chr1:162,775,707-162,775,707 View the variant detail on this assembly version. |
HGVS
| Type | Transcript | Protein |
|---|---|---|
| RefSeq | NM_006182.2:c.1912A>T | NP_006173.2:p.Ile638Phe |
| NM_001014796.1:c.1912A>T | NP_001014796.1:p.Ile638Phe | |
| Ensemble | ENST00000446985.6:c.1912A>T | ENST00000446985.6:p.Ile638Phe |
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
ClinVar
| Clinical Significance |
|
| Review star | ![]() |
| Show details | |
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
CIViC
| Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
|---|---|---|---|---|---|---|---|---|---|
| lung non-small cell carcinoma | Dasatinib | D |
|
|
Sensitivity/Response | Somatic | 4 | 22328973 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| In 3T3 fibroblasts expressing the I638F mutation have to be sensitive to the tyrosine kinase inhibit... | CIViC Evidence | Detail |
| NM_006182.4(DDR2):c.1912A>T (p.Ile638Phe) AND Non-small cell lung carcinoma | ClinVar | Detail |
| NM_006182.4(DDR2):c.1912A>T (p.Ile638Phe) AND Squamous cell lung carcinoma | ClinVar | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs1057519789 dbSNP
- Genome
- hg19
- Position
- chr1:162,745,497-162,745,497
- Variant Type
- snv
- Reference Allele
- A
- Alternative Allele
- T
- Variant (CIViC) (CIViC Variant)
- I638F
- Transcript 1 (CIViC Variant)
- ENST00000367922.3
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/143
- Summary (CIViC Variant)
- DDR2 I638F has been shown to be a loss of function mutation, but also confers sensitivity to dasatinib in cell lines.
Genome browser
